About Pra Health Sciences Referral Program
Tell your Friends and Family Members about Pra Health Sciences Referral Program and get $300. You should have recently enlisted with PRA Health Sciences to allude relatives and friends.
Tell them a little about yourself with the goal that they can make a special ID, which permits them to connect you to your referrals. Add your friend’s email delivers to refer them for one of their studies.
How to Refer
The referred member must portion in an examination. Since the member may not fit the bill for the first examination for which they were referred, the referral allowance will in any case be paid if the member dosages on an investigation inside a year.
There is no restriction to the quantity of first time members you can allude for an examination and you don’t need to be an investigation member to allude others for our investigations.
Your alluded member must make reference to your first and last name during the pre-screening via telephone all together for the referral allowance to be paid.
The referred member must round out a referral card at the screening visit so we can record the referral. This progression is a key prerequisite for paying out the referral allowance.
In the event that you refer another first-time member who dosages, you could get up to $300.00; there is no restriction to the quantity of members you can allude to our investigations, anyway they should be first-time members.
You will be paid through ClinCard inside 10-business days from the date the referred member got study prescription.
About Pra Health Sciences
PRA Health Sciences is an agreement research association with central command in Raleigh, North Carolina that was established in 1982.
In 2013 the organization was gained by Kohlberg Kravis Roberts, which acquired the organization open November 2014 and kept up shares until September 2019.
PRA Health Sciences is an agreement research association (CRO) with central command in Raleigh, North Carolina that was established in 1982.
In August 2017 the organization procured Conshohocken-based genuine medical services information, examination, and innovation arrangements organization Symphony Health for US$530 million.
In November 2019 PRA reported it was collaborating with Johnson and Johnson drug arm Janssen Pharmaceutica in a first-of-its-sort decentralized clinical preliminary assessing the medication Invokana (canagliflozin) in grown-ups with cardiovascular breakdown, with protected or diminished
This milestone study will gather true proof through a versatile clinical preliminary stage.
Location
United States